Procalcitonin in detecting neonatal nosocomial sepsis

Arch Dis Child Fetal Neonatal Ed. 2012 Sep;97(5):F368-70. doi: 10.1136/fetalneonatal-2010-194100.

Abstract

Objective: To investigate the accuracy of procalcitonin (PCT) as a diagnostic marker of nosocomial sepsis (NS) and define the most accurate cut-off to distinguish infected from uninfected neonates.

Setting: Six neonatal intensive care units (NICUs).

Patients: 762 neonates admitted to six NICUs during a 28-month observational study for whom at least one serum sample was taken on admission.

Main outcome measures: Positive and negative predictive values at different PCT cut-off levels.

Results: The overall probability of an NS was doubled or more if PCT was >0.5 ng/ml. In very-low-birth-weight (VLBW) infants, a cut-off of >2.4 ng/ml gave a positive predictive value of NS near to 50% with a probability of a false-positive diagnosis of NS in about 10% of the patients.

Conclusions: In VLBW neonates, a serum PCT value >2.4 ng/ml prompts early empirical antibiotic therapy, while in normal-birth-weight infants, a PCT value ≤2.4 ng/ml carries a low risk of missing an NS.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcitonin / blood*
  • Calcitonin Gene-Related Peptide
  • Cross Infection / diagnosis*
  • Humans
  • Infant, Newborn
  • Infant, Very Low Birth Weight
  • Intensive Care Units, Neonatal
  • Likelihood Functions
  • Protein Precursors / blood*
  • ROC Curve
  • Sensitivity and Specificity
  • Sepsis / diagnosis*

Substances

  • CALCA protein, human
  • Protein Precursors
  • Calcitonin
  • Calcitonin Gene-Related Peptide